These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 12938075)

  • 1. Drug Development for Psychotropic, Cognitive-Enhancing, and Disease-Modifying Treatments for Alzheimer's Disease.
    Cummings J
    J Neuropsychiatry Clin Neurosci; 2021; 33(1):3-13. PubMed ID: 33108950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Not Available].
    Duning T
    MMW Fortschr Med; 2024 Apr; 166(7):27-28. PubMed ID: 38637378
    [No Abstract]   [Full Text] [Related]  

  • 3. Natural Course of Disease.
    West J Med Surg; 1855 Nov; 4(11):400. PubMed ID: 38211197
    [No Abstract]   [Full Text] [Related]  

  • 4. Alteration of a clinically meaningful outcome in the natural history of Alzheimer's disease by cholinesterase inhibition.
    Lopez OL; Becker JT; Saxton J; Sweet RA; Klunk W; DeKosky ST
    J Am Geriatr Soc; 2005 Jan; 53(1):83-7. PubMed ID: 15667381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholinesterase inhibitors in the treatment of Alzheimer's disease and related dementias.
    Masterman D
    Clin Geriatr Med; 2004 Feb; 20(1):59-68. PubMed ID: 15062487
    [No Abstract]   [Full Text] [Related]  

  • 6. Increased hippocampal plaques and tangles in patients with Alzheimer disease with a lifetime history of major depression.
    Rapp MA; Schnaider-Beeri M; Grossman HT; Sano M; Perl DP; Purohit DP; Gorman JM; Haroutunian V
    Arch Gen Psychiatry; 2006 Feb; 63(2):161-7. PubMed ID: 16461859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Factors that modify the natural course of Alzheimer's disease].
    López OL; Becker JT
    Rev Neurol; 2003 Jul 16-31; 37(2):149-55. PubMed ID: 12938075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Six and 18-month changes in mild to moderate Alzheimer's patients treated with acetylcholinesterase inhibitors: what can we learn for clinical outcomes of therapeutic trials?
    Cortes F; Portet F; Touchon J; Vellas B
    J Nutr Health Aging; 2007; 11(4):330-7. PubMed ID: 17653493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Strategies for the treatment of Alzheimer's disease. The 'ad continuum' concept].
    Boada Rovira M
    Rev Neurol; 2001 Jun 1-15; 32(11):1074-84. PubMed ID: 11562834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Medical treatment of Alzheimer's disease].
    López-Pousa S; Serra-Mestres J
    Rev Neurol; 1998 Jun; 26(154):1054-60. PubMed ID: 9658492
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.